gene editing (Synthego Inc)
86
Structured Review
Synthego Inc
gene editing
Gene Editing, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+editing/editing+gene/pm42269214-11-1-13
Average 86 stars, based on 1 article reviews
Gene Editing, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gene+editing/editing+gene/pm42269214-11-1-13
Average 86 stars, based on 1 article reviews
gene editing - by Bioz Stars,
2026-11
86/100 stars
Images
Related Articles
Sequencing:Article Title: Generation of an induced pluripotent stem cell and isogenic control line from a vascular Ehlers-Danlos Syndrome (vEDS) patient harboring a pathogenic c.755G>T in the COL3A1 gene. Article Snippet: Unique stem cell line identifiers JHUi007-AJHUi007-A-1 Alternative name(s) of stem cell lines JHUi007-A: vEDS Patient iPSC line – i0195 Clone 5 (C5) JHUi007-A-1: Isogenic control iPSC line – i0195 Clone D8 (D8) Institution Johns Hopkins University Contact information of the reported cell line distributor Kenneth R. Boheler: kbohele1@jh.edu Type of cell lines iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: N/A Sex: MaleEthnicity: N/A Cell Source Dermal fibroblast Method of reprogramming (if applicable) Sendai virus Evidence of the reprogramming transgene loss (including genomic copy absence/removal/silencing, if applicable) (if applicable) Reprogramming was performed and validated according to criteria established by hPSC-Reg. .. Biomarker Discovery:Article Title: Generation of an induced pluripotent stem cell and isogenic control line from a vascular Ehlers-Danlos Syndrome (vEDS) patient harboring a pathogenic c.755G>T in the COL3A1 gene. Article Snippet: Unique stem cell line identifiers JHUi007-AJHUi007-A-1 Alternative name(s) of stem cell lines JHUi007-A: vEDS Patient iPSC line – i0195 Clone 5 (C5) JHUi007-A-1: Isogenic control iPSC line – i0195 Clone D8 (D8) Institution Johns Hopkins University Contact information of the reported cell line distributor Kenneth R. Boheler: kbohele1@jh.edu Type of cell lines iPSC Origin Human Additional origin info (applicable for human ESC or iPSC) Age: N/A Sex: MaleEthnicity: N/A Cell Source Dermal fibroblast Method of reprogramming (if applicable) Sendai virus Evidence of the reprogramming transgene loss (including genomic copy absence/removal/silencing, if applicable) (if applicable) Reprogramming was performed and validated according to criteria established by hPSC-Reg. .. other:Article Title: Stem Cell Technology: The Only Constant Is Change Article Snippet: GEN Genetic Engineering & Biotechnology News Vol.. 39, No. 12, December 1, 2019 Copyright © GEN Publishing pp.. 46–48, 50 DOI: 10.1089/gen.39.12.13 Translational Medicine |